Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer

This publication has 15 references indexed in Scilit:

• Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial
  JNCI Journal of the National Cancer Institute, 1996
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1995
• A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: Report of radiation therapy oncology group 84-07
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• Experience with CHART
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Induction chemotherapy for non-small cell carcinoma of the lung: limitations and lessons
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 Patients
  JNCI Journal of the National Cancer Institute, 1991
• What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation?
  Radiotherapy and Oncology, 1985